2017-03-15,Aduro Biotech To Host Research And Development Day In New York
2017-03-10,Aduro Biotech Awarded East Bay Innovation Award For Its Contributions in Life Sciences And The San Francisco East Bay Community
2017-03-06,Aduro Biotech Announces Upcoming Data Presentations At The 2017 American Association For Cancer Research Annual Meeting
2017-03-02,Aduro Biotech Announces Upcoming Data Presentations At The Keystone Symposia On Cancer Immunology And Immunotherapy Conference
2017-03-01,Aduro Biotech Announces Fourth Quarter And Full Year 2016 Financial Results
2017-02-28,Aduro Biotech To Present At Two Investor Conferences In March
2017-02-17,3 Stocks Setting Up for Major Breakouts
2017-02-10,Aduro Biotech To Present At The Leerink Partners 6th Annual Global Healthcare Conference
2017-01-26,Aduro Biotech Announces Appointment Of Leading Immunotherapy And Oncology Experts To Scientific Advisory Board
2017-01-19,Aduro Biotech Enters Into Exclusive License Agreement For Proprietary Neoantigen Identification Technology
2017-01-09,Aduro Biotech Announces Clinical Collaboration With Merck To Evaluate The Combination Of Aduro's CRS-207 With Merck's KEYTRUDA® (pembrolizumab) For The Treatment Of Gastric Cancer
2016-12-27,Aduro Biotech To Present At The 35th Annual J.P. Morgan Healthcare Conference
2016-12-22,Commit To Purchase Aduro Biotech At $7.50, Earn 20.8% Annualized Using Options
2016-12-07,Trump's Drug Pricing Comment Sends Biotech Stocks Into Free-Fall
2016-12-06,Aduro Biotech Europe's Hans Van Eenennaam, Ph.D. And John Dulos, Ph.D. Honored With The Intellectual Property Owners Education Foundation's 43rd Inventor Of The Year Award for Contributions In The Discovery Of KEYTRUDA® (pembrolizumab)
2016-12-05,Aduro Biotech Announces Anti-CD27 Agonist, An Investigational Anti-Cancer Immunotherapy, Advancing In Collaboration With MSD
2016-12-03,Aduro Biotech Presents Preclinical Data Supporting Clinical Development Of Its Anti-APRIL Antibody, BION-1301, For The Treatment Of Multiple Myeloma
2016-11-21,Partial Clinical Hold Lifted And Enrollment Resumes For Aduro Biotech LADD Clinical Trials
2016-11-12,Aduro Biotech Highlights Positive Clinical Results From Second Cohort Of Phase 1b Mesothelioma Clinical Trial
2016-11-09,Aduro Biotech's Personalized LADD Therapy Featured In An Oral Presentation At SITC's New Cancer Immunotherapy Agents In Development Program
2016-11-07,Aduro Biotech Presents Preclinical Data Demonstrating Acute And Systemic Immune Activation Through STING Pathway Stimulation With ADU-S100
2016-11-03,Aduro Biotech Enters Oversold Territory (ADRO)
2016-11-02,Aduro Biotech Reports Third Quarter 2016 Financial Results
2016-10-24,Aduro Biotech Reports Partial Clinical Hold To Pause Enrollment In LADD Trials
2016-10-23,Aduro Biotech To Host Conference Call
2016-09-29,Aduro Biotech Enters Oversold Territory (ADRO)
2016-09-27,Aduro Biotech Presents Encouraging Preclinical Data Showing Combination Synergy Of Its Immunotherapy And Checkpoint Inhibitors To Increase Antitumor Efficacy
2016-09-26,Aduro Biotech's Stephen T. Isaacs Named 2016 Visionary Leader By Berkeley Chamber Of Commerce
2016-09-22,Aduro Biotech To Present At LEERINK Partners Roundtable Series
2016-09-20,First Week of ADRO November 18th Options Trading
2016-09-06,Aduro Biotech Appoints Oncology Expert And Industry Veteran Natalie Sacks, M.D. As Chief Medical Officer
2016-09-01,Aduro Biotech Announces New Corporate Offices And Laboratory Space
2016-08-04,Aduro Biotech (ADRO) Is Today's Strong On High Volume Stock
2016-08-04,Aduro Biotech To Present At Canaccord Genuity Growth Conference
2016-08-03,Aduro Biotech Reports Second Quarter 2016 Financial Results
2016-06-09,Aduro Biotech To Present At NASDAQ Investor Conference
2016-06-04,Aduro Biotech Presents Encouraging Anti-Tumor Response Data From Ongoing Phase 1b Study In Malignant Pleural Mesothelioma At ASCO
2016-05-17,Ratings Changes Today
2016-05-16,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces The Commencement Of An Investigation Into Possible Securities Fraud Violations By Certain Officers And Directors Of Audro BioTech, Inc.
2016-05-16,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Aduro BioTech, Inc. - ADRO
2016-05-16,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Aduro BioTech, Inc. (ADRO)
2016-05-16,Aduro Biotech Becomes Oversold (ADRO)
2016-05-16,Aduro Biotech Pancreatic Cancer Immunotherapy Fails Mid-Stage Study
2016-05-16,Aduro Biotech Announces Phase 2b ECLIPSE Trial Misses Primary Endpoint In Heavily Pretreated Metastatic Pancreatic Cancer
2016-05-15,Aduro Biotech To Host Conference Call
2016-05-12,Aduro Biotech Announces First Patient Dosed In Phase 1 Study Of ADU-S100 For The Treatment Of Cutaneously Accessible Tumors
2016-05-11,Aduro Biotech Announces Management Promotions
2016-05-02,Aduro Biotech Announces First Quarter 2016 Financial Results
2016-04-28,Aduro Biotech Announces Key Preclinical Data Published Highlighting New Approach To Treat Multiple Myeloma
2016-04-27,Aduro Biotech To Present At Two Upcoming Investor Conferences
2016-04-26,7 Stocks Rising on Big Volume -- Here's How to Trade Them Now
2016-04-22,These 5 Stocks Are Poised for Breakouts
2016-04-11,Aduro Biotech Chief Scientific Officer To Highlight The Potential Of STING Activation In Cancer Immunotherapy In A Major Symposium At The 2016 American Association For Cancer Research Annual Meeting
2016-04-01,5 Stocks Poised for Big Breakouts
2016-03-29,Commit To Buy Aduro Biotech At $10, Earn 46.1% Annualized Using Options
2016-03-28,Aduro Biotech And UC Berkeley Launch Industry-Leading Immunotherapeutics And Vaccine Research Initiative
2016-03-24,Aduro Biotech Announces First Patient Dosed In Combination Clinical Trial Of CRS-207 And Epacadostat To Treat Ovarian Cancer
2016-03-08,Aduro Biotech Announces Fourth Quarter And Full Year 2015 Financial Results
2016-03-07,Aduro Biotech To Present At ROTH Conference
2016-02-03,Aduro Biotech To Present At Leerink Partners Global Healthcare Conference
2016-02-01,Aduro Biotech Receives $22.4 Million In Clinical Development Milestone Payments From Janssen
2016-01-25,Aduro Biotech Appoints Aimee Luck Murphy As Vice President Of Clinical Development And Operations
2016-01-11,Oversold Conditions For Aduro Biotech (ADRO)
2016-01-07,Aduro Biotech To Present At JP Morgan Healthcare Conference
2016-01-05,Aduro Biotech Expands Patent Portfolio With Key Newly Issued Composition And Methods Patents
2015-12-21,Aduro Biotech Announces Initiation Of Phase 1 Study Of ADU-741 For The Treatment Of Prostate Cancer
2015-12-16,Aduro Biotech Receives Milestone Payment From Janssen For Acceptance Of Investigational New Drug Application For ADU-741 In Prostate Cancer
2015-12-14,Aduro Biotech Receives Orphan Drug Designation In The European Union For CRS-207 And GVAX Pancreas For The Treatment Of Pancreatic Cancer
2015-12-10,Aduro Biotech Announces First Patient Dosed In Phase 1 Study Of ADU-214 For The Treatment Of Lung Cancer
2015-12-02,Aduro Biotech To Present At Oppenheimer Healthcare Conference
2015-12-01,Analysts' Actions -- CBS, Cummins, Campbell Soup, WhiteWave Foods and More
2015-11-27,Aduro Biotech To Present At NASDAQ Investor Conference
2015-11-24,Aduro Biotech Confirms All Clinical Trials Continue Unaltered And As Planned
2015-11-23,Aduro Biotech Receives Orphan Drug Designation In The European Union For CRS-207 For The Treatment Of Mesothelioma
2015-11-23,Aduro Biotech Announces Third Quarter 2015 Financial Results
2015-11-20,Aduro Biotech Europe's Chief Scientific Officer, Andrea Van Elsas, Ph.D. Featured As Keynote Speaker On Immunomodulatory Antibodies At ESMO Symposium On Immuno-Oncology 2015
2015-11-19,Aduro Biotech Establishes European Subsidiary
2015-11-18,Aduro Biotech Receives Milestone Payment From Janssen For Submission Of Investigational New Drug Application For ADU-741 In Prostate Cancer
2015-11-09,Aduro Biotech Announces Five Poster Presentations At The Society Of Immunotherapy Of Cancer Annual Meeting
2015-11-04,Aduro Biotech To Present At Credit Suisse Healthcare Conference
2015-10-29,Aduro Biotech Receives Milestone Payment From Janssen For Acceptance Of Investigational New Drug Application For ADU-214 In Lung Cancer
2015-10-28,Aduro Biotech And Protein Potential Present Data Demonstrating Novel Vaccine Offers 100% Protection In Malarial Model
2015-10-08,Aduro Biotech Receives Milestone Payment From Janssen For Submission Of Investigational New Drug Application For ADU-214 In Lung Cancer
2015-09-26,Aduro Biotech Announces Phase 1b Mesothelioma Trial Featured In Spotlight Poster At ESMO/ECC
2015-09-24,Aduro Biotech Enters Into Definitive Agreement To Acquire Premier Antibody Portfolio And Engineering Capabilities Through Purchase Of BioNovion
2015-09-23,Aduro Biotech To Participate In Leerink Partners Immuno-Oncology Roundtable
2015-09-21,Aduro Biotech Appoints Blaine Templeman As Executive Vice President, General Counsel And Secretary
2015-09-09,Aduro Biotech Announces Clinical Trial Agreement To Evaluate Combination Of Two Novel Cancer Immunotherapies For The Treatment Of Ovarian Cancer
2015-09-08,Aduro Biotech Completes Enrollment In Phase 2b ECLIPSE Trial In Metastatic Pancreatic Cancer
2015-09-02,Aduro Biotech To Present At BioCentury's NewsMakers In The Biotech Industry Conference
2015-08-20,Sentiment for Advaxis Back to Bullish With Broadfin and Inovio Deal
2015-08-10,Aduro Biotech Announces Second Quarter 2015 Financial Results
2015-08-10,Aduro Biotech Completes Enrollment In Phase 1b Clinical Trial Of CRS-207 Immunotherapy For The Treatment Of Mesothelioma
2015-08-06,Aduro Biotech To Present At The 35th Annual Canaccord Genuity Growth Conference
2015-06-29,Aduro Biotech Announces Immunotherapy Regimen Successfully Passes Futility Analysis In Phase 2b ECLIPSE Trial In Metastatic Pancreatic Cancer
2015-06-26,Aduro Biotech Appoints Industry Veteran, Stephen Sherwin, M.D., To Its Board Of Directors
2015-06-02,Aduro Biotech Appoints Liana Wu As Vice President Of Commercial
2015-06-01,Aduro Biotech Announces ASCO Presentation Of Encouraging Data From Ongoing Phase 1b Clinical Trial Of Its Immunotherapy For The Treatment Of Mesothelioma
2015-05-29,Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
2015-05-28,Aduro Biotech Announces First Quarter 2015 Financial Results
2015-05-07,Aduro Biotech's Preclinical Results For Its STING-Targeted CDN Immuno-Oncology Platform Highlighted In Prestigious Peer-Reviewed Publications
2015-05-06,Aduro Biotech To Present At Bank Of America Merrill Lynch 2015 Health Care Conference
2015-04-20,Aduro Biotech Announces Close Of Initial Public Offering, Including Full Exercise Of Underwriters' Option To Purchase Additional Shares, And Concurrent Private Placement
2015-04-17,IPO Market 'Has Been a Lonely Place' but Pace Is Picking Up
2015-04-15,Cancer Immunotherapy Remains Hot as Aduro Biotech Doubles in Value On IPO Debut
2015-04-14,Advaxis Shares Rise Ahead of Aduro's Rival Cancer Immunotherapy IPO
,
,
